Primaquine for vivax malaria in G6PD-intermediate or deficient adults
Part of Blood & lymphatic, Genetic & congenital, Hormones & metabolism, Infections clinical trials.
This trial tests how well the drug primaquine works for people with vivax malaria who have intermediate or low levels of an enzyme called G6PD. It aims to find safe and effective treatment options for this group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed vivax malaria infection (and no other type of malaria).
- Your G6PD level is intermediate (30% to less than 70% of normal) or deficient (30% or less of normal).
- You currently have a fever (temperature 37.5°C or higher) or have had a fever in the last 48 hours.
- You are 18 years old or older.
- Your hemoglobin level (a measure of red blood cells) is at least 8 g/dL.
- You live in the study area and are willing to be monitored for 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a revised dose of a medicine called tafenoquine to more effectively cure vivax malaria (a type of malaria that can come back). It is for people with normal G6PD enzyme levels and a current fever from vivax malaria.
This trial tests a combination of antimalarial drugs (tafenoquine plus artemisinin-based combination therapies) to see if it's safe and effective for treating vivax malaria. Participating may help clear the infection and prevent it from coming back.
This study tests how the malaria medicine tafenoquine is processed in the bodies of young children with vivax malaria. It helps find the right dose for small children and ensures the treatment is safe and effective.
This trial tests a shorter course of the drug primaquine to prevent relapse of vivax malaria, a recurring type of malaria. It may offer a faster recovery with fewer doses.
This study tests a medicine given to mothers after childbirth to see how it passes into breast milk and if it is safe for babies. It may help prevent malaria relapse in mothers who have had vivax malaria.
This study compares two medicines (tafenoquine and primaquine) taken with chloroquine to treat P. vivax malaria. It aims to see which is safer and works better in Indian participants aged 2 to 64.
Hear when a new Vivax Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.